Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société CEREVEL THERAPEUTICS HOLDINGS, INC.
01/10CEREVEL THERAPEUTICS TO PRESENT AT 4 : Additional Details of Phase 2 Program for Emraclidi..
AQ
01/03Cerevel to Present at the 40th Annual J.P. Morgan Healthcare Conference
AQ
2021CVL-231 : Results From an Early Proof-Of-Concept Study in Patients With Schizophrenia
PU
2021CEREVEL THERAPEUTICS : Evaluation of M4 Muscarinic Receptor Occupancy by CVL-231 in Nonhum..
PU
2021Cerevel Therapeutics Corporate Presentation
PU
2021Cerevel Therapeutics Reports Third Quarter 2021 Financial Results and Pipeline Updates ..
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial ..
AQ
2021Cerevel Therapeutics to Participate at Upcoming Virtual Investor Conferences
AQ
2021CEREVEL THERAPEUTICS : to Report Third Quarter 2021 Financial Results on Wednesday, Novemb..
AQ
2021CEREVEL THERAPEUTICS : R&D Day Presentation
PU
2021CEREVEL THERAPEUTICS : Hosts Virtual R&D Event to Review CVL-871 in Dementia-Related Apath..
GL
2021CEREVEL THERAPEUTICS : Announces Departure of CFO Kathy Yi (Form 8-K)
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, Regulatio..
AQ
2021CEREVEL THERAPEUTICS : Announces Departure of CFO Kathy Yi
AQ
2021CEREVEL THERAPEUTICS : to Present at Upcoming Virtual Investor Conferences
AQ
2021CEREVEL THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021CEREVEL THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Business Updates ..
PU
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021CEREVEL THERAPEUTICS : Announces Redemption of Public Warrants (Form 8-K)
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2021CEREVEL THERAPEUTICS : Announces Redemption of Public Warrants
AQ
2021CEREVEL THERAPEUTICS : to Report Second Quarter 2021 Financial Results on Wednesday, Augus..
AQ
2021CEREVEL THERAPEUTICS : Announces Pricing of $350 Million Public Offering of Common Stock (..
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (for..
AQ
2021CEREVEL THERAPEUTICS : Announces Positive Topline Results for CVL-231 in Phase 1b Clinical..
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial St..
AQ
2021CEREVEL THERAPEUTICS : Topline Results for CVL-231 in Phase 1b Clinical Trial in Patients ..
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Submission of Matters to a Vote of Security Holders ..
AQ
2021CEREVEL THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, Regulatio..
AQ
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Regulati..
AQ
2021CEREVEL THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2021CEREVEL THERAPEUTICS : Corporate Presentation
PU
2021CEREVEL THERAPEUTICS : to Present at the Cowen 41st Annual Health Care Conference
AQ
2021CEREVEL THERAPEUTICS : Hosts Inaugural Virtual R&D Event to Review Darigabat (CVL-865) and..
AQ
2021CEREVEL THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, Financial..
AQ
2021CEREVEL THERAPEUTICS : Announces the Appointments of Deval Patrick and Deborah Baron to it..
AQ
2020CEREVEL THERAPEUTICS HOLDINGS, INC. : Change in Directors or Principal Officers, Financial..
AQ
2020CEREVEL THERAPEUTICS : Announces the Appointment of Dr. Ruth McKernan to its Board of Dire..
AQ
2020CEREVEL THERAPEUTICS : to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Confer..
AQ
2020CEREVEL THERAPEUTICS : to Present at the Evercore ISI 3rd Annual HealthCONx Virtual Confer..
AQ
2020CEREVEL THERAPEUTICS HOLDINGS, INC. : Changes in Registrant's Certifying Accountant, Finan..
AQ
2020CEREVEL THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Key Business Hig..
AQ
2020CEREVEL THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A)
AQ
2020CEREVEL THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
2020CEREVEL THERAPEUTICS : Announces Third Quarter 2020 Financial Results and Key Business Hig..
AQ
2020CEREVEL THERAPEUTICS : to Present at Upcoming Virtual Investor Conferences
AQ
2020CEREVEL THERAPEUTICS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completi..
AQ
2020CEREVEL THERAPEUTICS : Announces First Patients Dosed in all Phase 3 Trials of Tavapadon f..
AQ
2020ARYA SCIE : Cerevel Therapeutics Announces First Patients Dosed in all Phase 3 Trials of T..
AQ
Upcoming event on CEREVEL THERAPEUTICS HOLDINGS, INC.
03/23/22